Vasopressin Infusion
Syringe pump continuous infusion preparation (1 unit/mL), hemodynamic titration, and extravasation surveillance protocol.
Syringe Pump Infusion Preparation (Standard Concentration)
| Ampoule Presentation | 1 mL ampoule (20 units/mL of vasopressin) |
|---|---|
| Vasopressin Dose | 40 units (2 mL = two 1 mL ampoules) |
| Compatible Diluent | 38 mL of 0.9% Sodium Chloride (NS) or D5W |
| Final Syringe Volume | 40 mL |
| Final Concentration | 1 unit/mL |
| Stability | 24 hours at room temperature |
Materials Required
- Vasopressin ampoules 20 units/mL (1 mL) × 2
- 60 mL Luer-lock syringe
- 0.9% Sodium Chloride (NS) or D5W
- Sterile drawing-up needle / filter needle
- Dedicated syringe pump infusion label
- Extension line (100 cm)
- Alcohol chlorhexidine swabs
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, body weight, and clinical indication.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Ampoule Check: Check each vasopressin ampoule for:
- Correct drug and strength, vasopressin (20 units/mL)
- Expiry date
- Container integrity, clarity, and absence of precipitate or discoloration
- Withdrawal: Open two ampoules of vasopressin. Withdraw 1 mL from each ampoule into a 60 mL Luer-lock syringe (Total vasopressin drawn: 2 mL = 40 units vasopressin).
- Dilution: Add 38 mL of 0.9% Sodium Chloride or D5W to a final volume of 40 mL.
- Mixing: Gently invert the syringe several times to ensure uniform mixing.
- Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Syringe Pump Setup: Prime the extension set, install into the syringe pump, and shield from excessive ambient light.
🔒 Lumen Policy: vasopressin is physically and chemically incompatible with numerous medications. It must be infused via a dedicated central venous catheter lumen whenever possible.
⚠️ Peripheral Administration: In an emergency situation, vasopressin may be infused peripherally for short-term bridging use only, with frequent site monitoring for extravasation.
Administration & Titration
Recommended Dosing Parameters
- Administration Route: Administer via syringe pump; dedicated central line lumen preferred.
- Recommended Starting Dose: 0.01 to 0.03 units/min (titrate infusion to achieve desired hemodynamic result).
- ICU Titration Range: 0.01 to 0.06 units/min.
- High-Dose Range: Higher doses may be used depending on clinical condition under direct intensivist supervision.
- Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.
Hemodynamic Monitoring Requirements
- Monitor arterial blood pressure continuously (invasive arterial line preferred).
- Monitor heart rate and continuous ECG rhythm.
- Monitor for peripheral tissue ischemia or necrosis.
- Assess end-organ perfusion markers (urine output, mental status, peripheral pulse volume, serum lactate).
Extravasation Surveillance & Response Protocol
Extravasation of potent vasopressors causes severe local vasoconstriction leading to ischemic sloughing and necrosis.
Normal Infusion Site
- No cutaneous blanching
- No local swelling
- No pain, burning, or stinging
- No tissue discolouration
Extravasation Suspected:
- STOP infusion immediately (do not flush line).
- Notify clinician promptly.
- Aspirate residual drug through the cannula if possible, then remove catheter.
- Document event in patient clinical record.